Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000

Chang, Stella; Long, Stacey R.; Kutikova, Lucie; Bowman, Lee; Finley, Denise; Crown, William H.; Bennett, Charles L.

doi:10.1200/jco.2004.10.170

Cited by 190 publications

(151 citation statements)

References 17 publications

Supporting

Mentioning

148

Contrasting

Order By: Relevance

“…27 Similarly, a recent cost effectiveness study on heart failure clinics in Ontario, Canada determined that the per patient per year cost in standard clinics was $15 987 (2008 CDN $). 28 Finally, Chang et al 29 determined the mean total costs per patient for cancer were $39 155 (2004 CDN $). Understanding the differences in the utilization requirements across the care continuum of the various diseases and populations is important for comparative costing.…”

Section: Discussionmentioning

confidence: 99%

Direct costs of adult traumatic spinal cord injury in ontario

et al. 2012

View full text Add to dashboard Cite

), from the time of initial hospitalization to 1 year after initial acute discharge among individuals with traumatic spinal cord injury (SCI). Setting: Ontario, Canada. Methods: Health system costs were calculated for 559 individuals with traumatic SCI (C1-T12 AIS A-D) for acute inpatient, emergency department, inpatient rehabilitation (that is, short-stay inpatient rehabilitation), complex continuing care (CCC) (i.e., longstay inpatient rehabilitation), home care services, and physician visits in the year after index hospitalization. All care costs were calculated from the government payer 0 s perspective, the Ontario Ministry of Health and Long-Term Care. INTRODUCTIONSpinal cord injury (SCI) results in a variety of acute motor, sensory and autonomic impairments typically requiring tertiary care and rehabilitation to optimize patient outcomes. In the province of Ontario, advances in prehospital (critical), acute care and early surgical decompression 1 have resulted in improved survival and an increasing number of persons with SCI seeking specialized rehabilitation services to augment their neurologic and functional recovery. Accompanying reduced acute care lengths of stay before inpatient rehabilitation admission are changing the required resource intensity and service provision models. 2 After discharge from inpatient rehabilitation, individuals with SCI continue to be predisposed to multiple impairments, and an increased propensity for related secondary health complications. 3 In the months and years after the initial acute care episode, previous research has demonstrated that increased risk of secondary complications is associated with frequent physician contact and hospitalizations. [4][5][6][7] This finding was recently supported by our research team in two studies on physician utilization and rehospitalization among adults with traumatic SCI in Ontario,

show abstract

Section: Discussionmentioning

confidence: 99%

Direct costs of adult traumatic spinal cord injury in ontario

et al. 2012

View full text Add to dashboard Cite

show abstract

“…The design and intent of these studies vary. In general, the studies 1) estimate the economic burden nationally, [13][14][15][16][17][18] 2) estimate the cost per patient of specific tumor types, [13][14][15][19][20][21][22][23] 3) examine the cost impact of stage of disease or of metastatic disease, 16,17,19,[22][23][24][25][26][27][28][29][30] or 4) evaluate the cost impact of different treatments on specific tumor types. [30][31][32][33][34][35] Methodologically, some studies have used a control group to estimate the incremental cost attributable to cancer, whereas other studies have itemized costs that the investigators considered cancer-related or attributed to cancer the total healthcare cost of patients with the disease.…”

Section: Discussionmentioning

confidence: 99%

Economic burden of metastatic bone disease in the U.S.

Schulman

Kohles

2007

Cancer

202

135

View full text Add to dashboard Cite

BACKGROUNDPrevious research has documented the prevalence of primary bone cancer; however, there are few data available regarding the impact of metastatic bone disease (MBD) on national expenditure. In this study, the authors quantified the prevalence and direct medical care costs of patients with MBD and the resulting cost impact on U.S. oncology expenditure.METHODSAnonymous, patient‐level data on health care utilization and cost were obtained from the Thomson Medstat MarketScan research databases. In total, 396,200 patients who were diagnosed with cancer between 2000 and 2004 were selected for the study. Patients with MBD were matched subsequently to non‐MBD controls. A 2‐part linear regression model was used to compare cases with controls to quantify the incremental cost associated with the disease.RESULTSCancer prevalence in the U.S. during the study period was estimated at 4,861,987 cases annually, and 5.3% (n = 256,137) of those patients had MBD. Rates of MBD were highest in patients with multiple myeloma (28.8%) and lung cancer (15.6%). The mean direct medical cost for all cancers combined was $75,329 for patients with MBD and $31,382 for controls. Regression‐adjusted, incremental costs were $44,442 (P < .001) across all cancer types. The incremental cost was highest for patients with multiple myeloma ($63,455) and lowest for patients with lung cancer ($24,946).CONCLUSIONSThe national cost burden for patients with MBD was estimated at $12.6 billion, which is 17% of the $74 billion in total direct medical cost estimated by the National Institutes of Health, suggesting that MBD is a significant driver of overall oncology cost. Cancer 2007. © 2007 American Cancer Society.

show abstract

“…A previous study estimated the average monthly costs of treated patients with non-infectious uveitis in 2009 ranging from US$ 1144 to US$ 2689, depending on the treatment regimens, which indicates that monthly healthcare costs are similar to those with diabetes mellitus and cancer patients. [15][16][17] Moreover, the costs associated with uveitis care measured only costs of medications and did not include the costs associated with hospital visits and intraocular surgeries.…”

Section: Eyementioning

confidence: 99%

Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up

Groen

Ramdas

Hoog

et al. 2016

Eye

View full text Add to dashboard Cite

Purpose To describe the visual outcomes and morbidity of newly referred uveitis patients. Methods Retrospective cohort study of 133 newly referred uveitis patients with active uveitis who required care in a tertiary center for at least 1 year. Main outcomes were best-corrected visual acuity (BCVA) at referral and 1 year after referral, duration of visual impairment, systemic medications used, as well as all complications and surgeries during the first year of follow-up. Generalized estimating equation models was used to assess prognosticators for poor BCVA. Results The mean age at onset of uveitis was 43 years. The proportion of patients with at least one eye with BCVA ≤ 0.3 decreased from 35% at referral to 26% (P = 0.45) at 1-year follow-up. The mean duration of visual impairment in the first year after referral was 4 months per affected eye. At 1-year follow-up, bilateral visual impairment was observed in 4% but at least one ocular complication developed in 66% and 30% of patients required at least one intraocular surgery. Systemic immunosuppressive treatment was required in 35% of patients and the mean number of visits to ophthalmologist was 11 per year, while 8% of patients required hospital admission. Prognosticators for poor visual outcome included surgery undergone before referral (odds ratio (OR), 3; 95% CI, 1-11; P = 0.047), visual impairment at referral (OR, 21; 95% CI, Po0.001), and glaucoma before referral (OR, 7; 95% CI, 2-28; P = 0.007). Conclusions Patients with severe uveitis had a favorable BCVA 1 year after referral with only 4% of patients having bilateral visual impairment. This, in contrast to the prolonged duration of visual impairment during the first year of follow-up and the demanding care.

show abstract

Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000

Cited by 190 publications

References 17 publications

Direct costs of adult traumatic spinal cord injury in ontario

Direct costs of adult traumatic spinal cord injury in ontario

Economic burden of metastatic bone disease in the U.S.

Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up

Contact Info

Product

Resources

About